More articles from Review

Predictors of progression in systemic sclerosis patients with interstitial lung disease
Oliver Distler, Shervin Assassi, Vincent Cottin, Maurizio Cutolo, Sonye K. Danoff, Christopher P. Denton, Jörg H.W. Distler, Anna-Maria Hoffmann-Vold, Sindhu R. Johnson, Ulf Müller Ladner, Vanessa Smith, Elizabeth R. Volkmann, Toby M. Maher

European Respiratory Journal May 2020, 55 (5) 1902026; DOI: 10.1183/13993003.02026-2019
Clinical utility of fractional exhaled nitric oxide in severe asthma management
Andrew Menzies-Gow, Adel H. Mansur, Christopher E. Brightling

European Respiratory Journal Mar 2020, 55 (3) 1901633; DOI: 10.1183/13993003.01633-2019
Defining severe obstructive lung disease in the biologic era: an endotype-based approach
Richard J. Martin, Elisabeth H. Bel, Ian D. Pavord, David Price, Helen K. Reddel

European Respiratory Journal Nov 2019, 54 (5) 1900108; DOI: 10.1183/13993003.00108-2019
The emerging role of mast cell proteases in asthma
Gunnar Pejler

European Respiratory Journal Oct 2019, 54 (4) 1900685; DOI: 10.1183/13993003.00685-2019
Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases
Lutz Wollin, Jörg H.W. Distler, Elizabeth F. Redente, David W.H. Riches, Susanne Stowasser, Rozsa Schlenker-Herceg, Toby M. Maher, Martin Kolb

European Respiratory Journal Sep 2019, 54 (3) 1900161; DOI: 10.1183/13993003.00161-2019
The Global Initiative for Asthma (GINA): 25 years later
Louis-Philippe Boulet, Helen K. Reddel, Eric Bateman, Søren Pedersen, J. Mark FitzGerald, Paul M. O'Byrne

European Respiratory Journal Aug 2019, 54 (2) 1900598; DOI: 10.1183/13993003.00598-2019
Detection, survival and infectious potential of Mycobacterium tuberculosis in the environment: a review of the evidence and epidemiological implications
Leonardo Martinez, Renu Verma, Julio Croda, C. Robert Horsburgh, Katharine S. Walter, Nicholas Degner, Keren Middelkoop, Anastasia Koch, Sabine Hermans, Digby F. Warner, Robin Wood, Frank Cobelens, Jason R. Andrews

European Respiratory Journal Jun 2019, 53 (6) 1802302; DOI: 10.1183/13993003.02302-2018
Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report
Vanessa M. McDonald, James Fingleton, Alvar Agusti, Sarah A. Hiles, Vanessa L. Clark, Anne E. Holland, Guy B. Marks, Philip P. Bardin, Richard Beasley, Ian D. Pavord, Peter A.B. Wark, Peter G. Gibson

European Respiratory Journal May 2019, 53 (5) 1802058; DOI: 10.1183/13993003.02058-2018
Obstructive sleep apnoea and venous thromboembolism: pathophysiological links and clinical implications
Alberto García-Ortega, Eva Mañas, Raquel López-Reyes, María José Selma, Aldara García-Sánchez, Grace Oscullo, David Jiménez, Miguel Ángel Martínez-García

European Respiratory Journal Feb 2019, 53 (2) 1800893; DOI: 10.1183/13993003.00893-2018
Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature
Timm Volmer, Timo Effenberger, Christoph Trautner, Roland Buhl

European Respiratory Journal Oct 2018, 52 (4) 1800703; DOI: 10.1183/13993003.00703-2018

Main menu

User menu

Search

More articles from Review

Pages

Contact us